EXTREME CONFLICT OF INTEREST — EYE-OPENING NEW REPORT ON THE FDA

 In big pharma

Did you know that the FDA gets MILLIONS in funding from the pharmaceutical industry — the industry it is supposed to independently regulate.

“It is often said that some government regulator or another is in the pocket of industry. In the case of the Food and Drug Administration, it’s a fact prescribed by federal law,” states the new report from the Project On Government Oversight (POGO).

“The agency, whose responsibilities include making sure that prescription drugs sold in the United States are safe and effective, receives almost three-quarters of its funding for that work from drug makers. In Fiscal Year 2015, the agency spent about $1.1 billion on prescription drug oversight—more specifically, those activities the agency categorizes as part of its “process for the review of human drug applications.” Congress delivered 29 percent of that money—$331.6 million. Drug companies provided the rest—$796.1 million.”

THIS IS SCANDALOUS! It’s time to take back our health and do our own research — the FDA can no longer be trusted to protect Americans from drugs and vaccines that are NOT safe. Please do your own research and know everything that goes into your body and the very real side effects.

 


 

FDA Depends on Industry Funding; Money Comes with “Strings Attached”

It is often said that some government regulator or another is in the pocket of industry.

In the case of the Food and Drug Administration, it’s a fact prescribed by federal law.

The bottom line: The FDA is addicted to drug money.

To understand how, consider the legally mandated process that has been playing out over the past year between regulators at the FDA and representatives of the drug industry they oversee.

From September 2015 to January 2016, teams of FDA officials held 70 meetings with drug company executives and lobbyists to set goals that could have far-reaching consequences for the pharmaceutical industry, the FDA, and anyone who uses or pays for prescription drugs.

At issue: How the Food and Drug Administration should go about approving new drugs.

The meetings, closed to the public, weren’t just talks. They were negotiations. And if the two sides didn’t reach an agreement, the FDA could find itself in a world of hurt.

The agency, whose responsibilities include making sure that prescription drugs sold in the United States are safe and effective, receives almost three-quarters of its funding for that work from drug makers. In Fiscal Year 2015, the agency spent about $1.1 billion on prescription drug oversight—more specifically, those activities the agency categorizes as part of its “process for the review of human drug applications.” Congress delivered 29 percent of that money—$331.6 million. Drug companies provided the rest—$796.1 million.

Over the past two decades, “user fees” paid by industry have climbed from 35 percent of the FDA’s spending on such oversight to 71 percent.

The bottom line: The FDA is addicted to drug money.

If drug companies merely wrote the checks, there might be less cause for concern. Indeed, many federal agencies collect user fees. However, at the FDA, as a study by the Institute of Medicine has observed, the corporate money comes with “strings that are attached.”

 

Read More >

Recommended Posts
Contact Us

Send us an email and we'll get back to you, asap.

Not readable? Change text.

Start typing and press Enter to search